Reversible suppression of allo-antibody production by cyclosporin A

Int Arch Allergy Appl Immunol. 1980;62(4):453-8. doi: 10.1159/000232548.

Abstract

Treatment of rats with 25 mg/kg/day of cyclosporin A suppressed their immune response to skin allografts. Withdrawal of cyclosporin A treatment led to complete recovery of specific immune responsiveness and the time taken for recovery was independent of the duration of treatment. Titration of the dose of cyclosporin A administered in vivo indicated that doses of 12 mg/kg/day or less were not fully immunosuppressive.

MeSH terms

  • Animals
  • Cyclosporins
  • Dose-Response Relationship, Immunologic
  • Graft Survival / drug effects
  • Immunoglobulin G
  • Immunosuppression Therapy*
  • Isoantibodies / biosynthesis*
  • Peptides, Cyclic / pharmacology*
  • Rats
  • Skin Transplantation
  • Time Factors
  • Transplantation, Homologous

Substances

  • Cyclosporins
  • Immunoglobulin G
  • Isoantibodies
  • Peptides, Cyclic